(PharmaNewsWire.Com, February 26, 2018 ) The Asia Pacific Gastroparesis Drugs market size was around USD 950 million in 2017. It is expected to grow at a CAGR of 5.5% to reach USD 1.24 billion by 2022. It captures 20% of the global market.
Normal spontaneous movements of the muscles in the stomach are affected when a person is suffering from Gastroparesis often causing vomiting, improper digestion etc. Erythromycin, reglan are few drugs prescribed for the treatment.
Augmenting geriatric population, increased number of surgeries causing Gastroparesis as a side effect, growing number of people with diabetes, and introduction of new drugs in the market for controlling symptoms like nausea are the major factors driving the growth of this market. Negative side effects of prescribed drugs, inordinate delays in regulatory approvals, and complicated diagnostic procedure are the major factors inhibiting market growth.
The market is segmented by drug type, disease class and end user. Classification by drug type entails Prokinetic Agents, Antiemetic Agents, and Botulinum Toxin Injections. Classification by disease class entails Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis, and Others. Idiopathic Gastroparesis lead the market in 2015 and will retain its position till 2022. Its causes are unknown. However, this condition can be managed by dietary management. Classification by end user entails Hospitals, Pharmacies, Clinics, and E-commerce.
Classification by geography entails India, China, Korea, Japan and others. Asia Pacific is the fastest growing market and is anticipated to remain so in the forecast period. Emerging economies of India and China are spearheading this growth spurt.
Key players in the market are Allergan, Plc., Abbott Laboratories (Abbott Arzneimittel GmbH), AstraZeneca Plc. Other players in the market are Cadila Pharmaceuticals Ltd., ETX Pharma, Inc, Evoke Pharma, GlaxoSmithKline Plc., Neurogastrx, Inc., Valeant Pharmaceuticals International, Inc., and Theravance Biopharma.
Market Segmentation: 1) Drug Class Introduction Prokinetic Agents Antiemetic Agents Botulinum Toxin Injections
2) Disease Type Introduction Diabetic Gastroparesis Idiopathic Gastroparesis Post-surgical Gastroparesis
3) End User Introduction Hospitals Pharmacies Clinics E-commerce
Scope of the Report: Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms product type along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analyzing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
